Booster dose vaccination for preventing hepatitis B
J Poorolajal, M Mahmoodi… - Cochrane database …, 2010 - cochranelibrary.com
J Poorolajal, M Mahmoodi, AA Haghdoost, R Majdzadeh, S Nasseri‐Moghaddam…
Cochrane database of systematic reviews, 2010•cochranelibrary.comBackground Antibodies against hepatitis B surface antigen (HBs) wane over time after
vaccination for hepatitis B (HB); hence, the duration of protection provided by the vaccine is
still unknown but may be evaluated indirectly by measuring the anamnestic immune
response to booster doses of vaccine. Objectives To assess the benefits and harms of
booster dose hepatitis B vaccination for preventing HB infection.
vaccination for hepatitis B (HB); hence, the duration of protection provided by the vaccine is
still unknown but may be evaluated indirectly by measuring the anamnestic immune
response to booster doses of vaccine. Objectives To assess the benefits and harms of
booster dose hepatitis B vaccination for preventing HB infection.
Background
Antibodies against hepatitis B surface antigen (HBs) wane over time after vaccination for hepatitis B (HB); hence, the duration of protection provided by the vaccine is still unknown but may be evaluated indirectly by measuring the anamnestic immune response to booster doses of vaccine.
Objectives
To assess the benefits and harms of booster dose hepatitis B vaccination for preventing HB infection.
cochranelibrary.com
以上显示的是最相近的搜索结果。 查看全部搜索结果